ACADIA Pharmaceuticals to Present at the 38th Annual J.P. Morgan Healthcare Conference on January 14, 2020
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company
focused on the development and commercialization of innovative medicines
that address unmet medical needs in central nervous system disorders,
today announced that it will present at the 38th Annual J.P.
Morgan Healthcare Conference in San Francisco on Tuesday, January 14,
2020, at 10:00 a.m. Pacific Time, followed by a question and answer
breakout session.
A live webcast of ACADIA's presentation and breakout session will be
accessible on the company's website, www.acadia-pharm.com,
under the investors section and an archived recording will be available
on the website through February 14, 2020.
About ACADIA Pharmaceuticals
ACADIA is a biopharmaceutical company focused on the development and
commercialization of innovative medicines to address unmet medical needs
in central nervous system disorders. ACADIA has developed and
commercialized the first and only medicine approved for the treatment of
hallucinations and delusions associated with Parkinson's disease
psychosis. ACADIA also has ongoing clinical development efforts in
additional areas with significant unmet need, including dementia-related
psychosis, major depressive disorder, the negative symptoms of
schizophrenia, and Rett syndrome. This press release and further
information about ACADIA can be found at: www.acadia-pharm.com.
Contentful, a leading composable content platform for digital-first businesses, today announced the general availability of Contentful Studio, its newest product. Contentful Studio empowers digital teams, including marketers and designers, to...
Pelago, the leading digital clinic partner to U.S. businesses and health plans for substance use management, today announced $58 million in new funding on the strength of customer growth and validated ROI, bringing total funding to $151 million....
Personalis, Inc. , a leader in advanced genomics for precision oncology, announced today that a podium talk and multiple abstracts featuring data for the company's NeXT Personal® whole genome-based, tumor-informed assay for ultra-sensitive ctDNA...
Brightly, a Siemens company and the global leader in intelligent asset management solutions, today announced the appointments of Christine Engle, senior vice president of people and operations, and Nigel Hughes, head of product, to its leadership...
AppViewX, the leader in automated machine identity management (MIM) and application security, and Fortanix, a leader in data-first security and pioneer of Confidential Computing, today announced a partnership to offer cloud-delivered secure digital...
StartupOS, a leader in StartupTech, today unveiled Bolt Startup AI, the industry's first generative AI-powered chatbot that helps founders use natural language to build, enhance, and scale their startup. The new tool also enables enterprise, private...